Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Vericel corporation symbols : NVS save search
Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published: 2023-09-26 (Crawled : 08:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.05%
H: 1.75%
C: 0.5%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: -0.92%
H: 0.24%
C: -3.93%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.46%
C: -0.31%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.49%
H: 0.65%
C: -0.56%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.16%
H: 0.13%
C: -0.32%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.38%
H: 1.7%
C: -1.85%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.02%
H: 1.37%
C: 1.21%
research market
Cell Therapy Market Value to Reach US$ 54.6 Bn by 2032, States TMR Study
Published: 2022-12-19 (Crawled : 13:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.0%
H: 0.09%
C: -0.32%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: -0.49%
H: 0.02%
C: -6.55%
therapy study market
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published: 2021-09-23 (Crawled : 12:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.42%
H: 1.55%
C: 0.38%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.86%
H: 2.12%
C: 1.89%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 0.5%
H: 0.58%
C: -5.62%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 1.11%
H: 2.8%
C: 2.53%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
therapy approval
Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players
Published: 2021-07-16 (Crawled : 16:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.1%
H: 0.34%
C: 0.11%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.84%
H: 0.05%
C: -0.35%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.23%
H: 0.41%
C: 0.12%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.26%
H: 0.04%
C: -1.85%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: 0.03%
H: 1.2%
C: 0.96%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.59%
H: 0.58%
C: -0.05%
research market
Advanced Therapy Medicinal Products Market Size Worth $21.2 Billion By 2028: Grand View Research, Inc.
Published: 2021-05-12 (Crawled : 08:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: -0.44%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: -4.6%
H: 4.8%
C: -1.06%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.44%
H: 1.27%
C: -1.14%
therapy research
Insights on the Advanced Therapy Medicinal Products Global Market to 2027 - Featuring Bluebird Bio, Celgene and Gilead Lifesciences Among Others
Published: 2021-04-26 (Crawled : 14:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.17%
H: 0.11%
C: -0.35%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 1.11%
H: 6.59%
C: 6.31%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 5.7%
H: 4.95%
C: 2.43%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 1.19%
H: 2.0%
C: 1.69%
therapy
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
Published: 2021-03-30 (Crawled : 22:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.55%
H: 0.51%
C: -0.22%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.01%
H: 0.25%
C: -0.82%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.74%
H: 5.83%
C: 4.75%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: -0.81%
H: 4.45%
C: 2.03%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.7%
H: 4.08%
C: 2.25%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 0.66%
H: 5.38%
C: 4.65%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.21%
H: 0.29%
C: -0.17%
gene therapies gene therapy therapy drug device drug delivery liver
Regenerative Medicine Market Revenue Worth $39,012 Million by 2030: P&S Intelligence
Published: 2021-03-16 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.32%
H: 0.53%
C: -0.11%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: 0.7%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.93%
H: 0.06%
C: -5.0%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.82%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.91%
H: 1.64%
C: 0.93%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.